NCT04673110

Brief Summary

Introduction: Colorectal surgery (CRS) is associated with high morbidity rates, being anastomotic leakage (AL) one of the most serious complications with an incidence as high as 15%, accounting for up to a third of mortality in these procedures. The identification of pre-clinical markers may allow an early diagnosis and a timely intervention. Objective: To compare the performance of neutrophil-to-lymphocyte ratio (NLR) vs C-reactive protein (CRP) as early predictors of AL in CRS. Methodology: A retrospectively analyzed consecutive patients who underwent a colorectal surgery with anastomosis from June 2015 to April 2019. Receiver-operating characteristic (ROC) curves were used to find the cutoff points with the best diagnostic performance of AL.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
116

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2015

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

December 12, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 17, 2020

Completed
Last Updated

December 17, 2020

Status Verified

December 1, 2020

Enrollment Period

3.8 years

First QC Date

December 12, 2020

Last Update Submit

December 12, 2020

Conditions

Keywords

neutrophil-to-lymphocyte ratioC-reactive proteinpreclinical markercolorectal surgerycomplications

Outcome Measures

Primary Outcomes (5)

  • Demographic variables

    sex and age

    2015-2019

  • inpatient stay

    days

    2015-2019

  • value of C-reactive protein

    normal value under 5 mg/dL

    2015-2019

  • value of Neutrophil to Lymphocyte Ratio

    It can be obtained from the blood count (the absolute neutrophil count divided by the absolute lymphocyte count)

    2015-2019

  • the timing of the operation

    elective or emergency

    2015-2019

Study Arms (2)

Anastomotic leakage group

9 patients developed anastomotic leakage (8%) in a median of 8 days (range: 5-9) median CRP level postoperative day 4:164mg/dL

Diagnostic Test: Neutrophil to Lymphocyte Ratio and C-reactive protein

no Anastomotic leakage group

117 patients (92%) median CRP level postoperative day 4: 64mg/dL

Diagnostic Test: Neutrophil to Lymphocyte Ratio and C-reactive protein

Interventions

Zahorec et al. identified the neutrophil-lymphocyte ratio (NLR) as an inflammation marker in critical patients, defining as the absolute neutrophil count divided by the absolute lymphocyte count

Anastomotic leakage groupno Anastomotic leakage group

Eligibility Criteria

Age19 Years - 90 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

116 patients

You may qualify if:

  • Patients older than 18 years.
  • All colorectal resections (open or laparoscopic).
  • Confection of a diverting loop ostomy.
  • Timing of surgery (urgent or scheduled).

You may not qualify if:

  • Patients under 18 years of age.
  • Patients with hematological diseases.
  • Patients with extra abdominal infections.
  • Patients with oncological diseases
  • Patients whit definitive colostomy (i.e. Miles operation),
  • Patients did not have a primary anastomosis (e.g. Hartmann's operation).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (7)

  • Paun BC, Cassie S, MacLean AR, Dixon E, Buie WD. Postoperative complications following surgery for rectal cancer. Ann Surg. 2010 May;251(5):807-18. doi: 10.1097/SLA.0b013e3181dae4ed.

    PMID: 20395841BACKGROUND
  • Alves A, Panis Y, Mathieu P, Mantion G, Kwiatkowski F, Slim K; Association Francaise de Chirurgie. Postoperative mortality and morbidity in French patients undergoing colorectal surgery: results of a prospective multicenter study. Arch Surg. 2005 Mar;140(3):278-83, discussion 284. doi: 10.1001/archsurg.140.3.278.

    PMID: 15781793BACKGROUND
  • Choy PY, Bissett IP, Docherty JG, Parry BR, Merrie A, Fitzgerald A. Stapled versus handsewn methods for ileocolic anastomoses. Cochrane Database Syst Rev. 2011 Sep 7;(9):CD004320. doi: 10.1002/14651858.CD004320.pub3.

    PMID: 21901690BACKGROUND
  • Kingham TP, Pachter HL. Colonic anastomotic leak: risk factors, diagnosis, and treatment. J Am Coll Surg. 2009 Feb;208(2):269-78. doi: 10.1016/j.jamcollsurg.2008.10.015. Epub 2008 Dec 4. No abstract available.

    PMID: 19228539BACKGROUND
  • Ortega-Deballon P, Radais F, Facy O, d'Athis P, Masson D, Charles PE, Cheynel N, Favre JP, Rat P. C-reactive protein is an early predictor of septic complications after elective colorectal surgery. World J Surg. 2010 Apr;34(4):808-14. doi: 10.1007/s00268-009-0367-x.

    PMID: 20049435BACKGROUND
  • Trencheva K, Morrissey KP, Wells M, Mancuso CA, Lee SW, Sonoda T, Michelassi F, Charlson ME, Milsom JW. Identifying important predictors for anastomotic leak after colon and rectal resection: prospective study on 616 patients. Ann Surg. 2013 Jan;257(1):108-13. doi: 10.1097/SLA.0b013e318262a6cd.

    PMID: 22968068BACKGROUND
  • Slankamenac K, Graf R, Barkun J, Puhan MA, Clavien PA. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg. 2013 Jul;258(1):1-7. doi: 10.1097/SLA.0b013e318296c732.

    PMID: 23728278BACKGROUND

MeSH Terms

Conditions

Anastomotic Leak

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
General Surgeon

Study Record Dates

First Submitted

December 12, 2020

First Posted

December 17, 2020

Study Start

June 1, 2015

Primary Completion

April 1, 2019

Study Completion

February 1, 2020

Last Updated

December 17, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Due to the sensitive nature of the study, patients were assured that the raw data would remain confidential and would not be shared.